MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
More news: Research
Written by / Agency / Source: Aciont, Inc.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Aciont® to Present at ARVO 2011 Annual Meeting - Aciont’s poster “Importance of the Conjunctiva in Transscleral Iontophoresis” will be shown on May 3 at the meeting - Aciont.com
Aciont® to Present at ARVO 2011 Annual Meeting

 

NewswireToday - /newswire/ - Salt Lake City, UT, United States, 2011/04/26 - Aciont’s poster “Importance of the Conjunctiva in Transscleral Iontophoresis” will be shown on May 3 at the meeting - Aciont.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Aciont Inc. announced today that the company will present findings on the ocular iontophoresis of macromolecules at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale, FL. Iontophoresis is a minimally invasive means to deliver drugs through tissue using a mild electrical current. “A number of research publications (in the transscleral iontophoresis area) are focusing on scleral tissue. This study reveals the importance of conjunctiva in ocular drug delivery, particularly when attempting to use in vitro results to predict the outcome of in vivo transscleral iontophoresis,” said Dr. Kongnara Papangkorn, Aciont’s Director of Research.

The lead author of the presentation is Dr. Sarah A. Molokhia who works with the John A. Moran Eye Center at The University of Utah. The poster A497 is titled “Importance of the Conjunctiva in Transscleral Iontophoresis,” and can be viewed on Tuesday May 3, 2011 from 1:45 – 3:30PM in Hall B/C at the Greater Fort Lauderdale Convention Center. Aciont personnel will be in attendance at the ARVO meeting to respond to questions regarding Aciont’s work.

Aciont, Inc. (aciont.com) is a specialty biopharmaceutical company endeavoring to become the world leader in commercializing localized, non-invasive (topical passive diffusion-based and iontophoretic), controlled and sustained release back of the eye therapeutics for sight threatening diseases such as severe uveitis, diabetic macular edema and age-related macular degeneration. Aciont’s goal is to provide ophthalmologists substantially greater freedom in treating and/or preventing chronic eye diseases through optimal drug dosing and improved patient/physician compliance. Aciont is located in Salt Lake City, Utah.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Research Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Aciont, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Research articles,
CATCH Visitors via Your Competitors Announcements!


Aciont® to Present at ARVO 2011 Annual Meeting

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Jillian Conrad - Aciont.com 
801-359-3461 admin[.]aciont.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Aciont, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Research via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Aciont, Inc. / Company Profile


Read Research Most Recent Related Newswires:

PPG Announces Partnership with Bradford Science Festival to Support Next-generation STEM Workforce
Peking University and Thales Sign A Contract to Develop A Very High Peak Power Laser System in China
University of Antwerp and Imec Launch Crowdscan - A New Spin-off to Measure Crowds without Compromising Personal Privacy
BASF Supports Search for Active Ingredients to Combat Coronavirus SARS-CoV-2
Bruker Corporation Announces Successful Installation of World’s First 1.2 GHz NMR System Enables Novel Functional Structural Biology Research
Innovation Platform Nexplore Forms Research Cooperation with TU Darmstadt
Increasing Demand for Real Time Access Boosts the Global Image Recognition Market At 21.00% CAGR According to Inkwood Research
Innovative MYRRHA Research Reactor Starting to Take Shape
BASF and BNP Brinkmann Acting as Project Partners to Support Current DLR Research on the Future of Mobility
BASF and CTIBiotech to Develop First 3D Bioprinted Human Reconstructed Skin Including Immune Macrophages
Bruker Announces Acquisition of Preclinical and Molecular Imaging Research Software Provider PMOD Technologies, LLC
Rohde & Schwarz and Martin Luther University Halle-Wittenberg Establish Research Partnership
Bruker and Champalimaud Foundation Announce Collaboration to Develop Novel Ultra-High Field 18 Tesla Preclinical MRI System and Applications
Biomedical Software Startup BostonGene Secures M in Series A Financing from NEC
Imec, UZ Leuven, KU Leuven, The Ghent University, Agilent, Western Digital and BlueBee Develop Unique Hybrid Cloud Platform

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  La Bella Bakery Artisan Bakery Arizona





 
  ©2020 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)